Correlation Between FCS Software and Emcure Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both FCS Software and Emcure Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining FCS Software and Emcure Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between FCS Software Solutions and Emcure Pharmaceuticals, you can compare the effects of market volatilities on FCS Software and Emcure Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in FCS Software with a short position of Emcure Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of FCS Software and Emcure Pharmaceuticals.

Diversification Opportunities for FCS Software and Emcure Pharmaceuticals

-0.12

Correlation Coefficient

FCS Software  Emcure Pharmaceuticals

Good diversification

The 3 months correlation between FCS and Emcure is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding FCS Software Solutions and Emcure Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emcure Pharmaceuticals and FCS Software is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on FCS Software Solutions are associated (or correlated) with Emcure Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emcure Pharmaceuticals has no effect on the direction of FCS Software i.e., FCS Software and Emcure Pharmaceuticals go up and down completely randomly.

Pair Corralation between FCS Software and Emcure Pharmaceuticals

Assuming the 90 days trading horizon FCS Software Solutions is expected to under-perform the Emcure Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, FCS Software Solutions is 1.58 times less risky than Emcure Pharmaceuticals. The stock trades about -0.05 of its potential returns per unit of risk. The Emcure Pharmaceuticals is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  100,800  in Emcure Pharmaceuticals on September 23, 2024 and sell it today you would earn a total of  37,870  from holding Emcure Pharmaceuticals or generate 37.57% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	92.86%
Values	Daily Returns

FCS Software Solutions  vs.  Emcure Pharmaceuticals

FCS Software Solutions

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days FCS Software Solutions has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, FCS Software is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Emcure Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Emcure Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Emcure Pharmaceuticals is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with FCS Software and Emcure Pharmaceuticals

The main advantage of trading using opposite FCS Software and Emcure Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if FCS Software position performs unexpectedly, Emcure Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emcure Pharmaceuticals will offset losses from the drop in Emcure Pharmaceuticals' long position.

The idea behind FCS Software Solutions and Emcure Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.